Navigation Links
Profil Institute Teams Up With American Diabetes Association to 'Step Out' Against Diabetes

SAN DIEGO, July 8 /PRNewswire/ -- Profil™ Institute for Clinical Research, Inc., a company specializing in early phase clinical trials for diabetes and obesity, announced today that Dr. Marcus Hompesch, the company's President and CEO, will serve as San Diego's 2010 Corporate Chairman for Step Out: Walk to Fight Diabetes, the American Diabetes Association's (ADA) largest fund-raising event.

Dr. Hompesch will help host the annual corporate community kick-off breakfast today at The University Club Atop Symphony Towers, where community and business leaders are invited to learn more about supporting the Step Out: Walk to Fight Diabetes in San Diego through corporate donations or by forming a team of walkers for the event.

The ADA's Step Out: Walk to Fight Diabetes raises about $20 million annually on a national level with more than 150 walks taking place in over 100 U.S. markets.  Step Out: Walk to Fight Diabetes in San Diego will take place Sunday, October 24 at De Anza Cove on Mission Bay.

"The event itself is truly inspirational when witnessing so many people and businesses unite together for a cause as vitally important as preventing this disease and raising funds for a cure," said Dr. Hompesch.  "For that reason, Profil Institute is proud to be teaming up with the ADA in the fight against diabetes and for its Step Out: Walk to Fight Diabetes fund-raising event in San Diego."  

About Profil™ Institute for Clinical Research, Inc.

Profil is a privately held institute providing high quality early phase clinical research services in diabetes and obesity. To date, the company has been involved with almost every clinically promising drug and device development in diabetes and in more than 120 clinical studies since its inception in 2004. Profil uses its expertise to guide the developmental planning, design and actual performance of early phase clinical studies that help in the determination of whether a new compound should be carried forward into the later phases of clinical development. The company's key scientists hail from academic centers including the WHO Collaborating Center of Diabetes at the Heinrich-Heine University of Düsseldorf, Columbia University, University of Michigan and Harvard University.

For more information visit

About American Diabetes Association

The ADA is the nation's leading non-profit charity providing diabetes research, information and advocacy.  Each year, hundreds of thousands of people participate in ADA fund-raising events across the country to increase awareness and raise millions of dollars in the fight against this disease. Founded in 1940, the Association funds research to prevent, cure and manage diabetes; delivers services to hundreds of communities; provides objective and credible information; and gives voice to those denied their rights because of diabetes.

For more information about corporate support or registering a team for San Diego's Step Out: Walk to Fight Diabetes, please contact Janell McCrensky, or 619.234.9897 x 7433.

SOURCE Profil Institute for Clinical Research, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
2. Two-Year Outcomes From Large Head-to-Head Clinical Trial Indicate Similar Safety Profile in Diabetic Patients for Cypher(R) Sirolimus-Eluting Coronary Stent and Taxus Stent
3. New Data From Large Safety Analysis of MYCAMINE Shows Favorable Clinical Safety Profile
4. ALS TDI Completes Gene Expression Profile of Lou Gehrigs Disease in Mice
5. Tumor Growth Inhibition and Pharmacokinetic Profile of NKTR-102 (PEG-Irinotecan) in Multiple Solid Tumors To Be Presented at Upcoming AACR-NCI-EORTC International Conference
6. Kosan Presents Phase 1 Data Showing Antitumor Activity and Safety Profile of Epothilone KOS-1584 at AACR/NCI/EORTC Meeting
7. Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
8. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
9. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
10. HUYA Bioscience Intl Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
11. Thomson Healthcare Cancer Profiler Used in Study
Post Your Comments:
(Date:6/26/2016)... One of Australia,s successful biotechnology scientists, Dr ... biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). Noxopharm ... on the ASX. Noxopharm is a clinic-ready company with ... 1 clinical study later this year. ... problems facing cancer patients - the ability of cancers to become ...
(Date:6/26/2016)... 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ... Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) expired ... Time). As previously announced on May 31, ... merger agreement under which Jazz Pharmaceuticals has commenced a ...
(Date:6/26/2016)... 2016  VMS Rehab Systems, Inc. ( ) ... measures required to build a strong and stable market ... listed on the OTC Markets-pink current trading platform. ... "We are seeing an anomaly in market trading activities ... by the Company, but shareholders and market players as ...
Breaking Medicine Technology:
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... 24, 2016 , ... Dr. Amanda Cheng, an orthodontist ... has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be used ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
Breaking Medicine News(10 mins):